Opendata, web and dolomites

HEADSpAcE SIGNED

Translational studies of HEAD and neck cancer in South America and Europe

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "HEADSpAcE" data sheet

The following table provides information about the project.

Coordinator
CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER 

Organization address
address: 150 COURS ALBERT THOMAS
city: LYON CEDEX 08
postcode: 69372
website: www.iarc.fr

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 3˙996˙233 €
 EC max contribution 3˙153˙447 € (79%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SC1-2018-Single-Stage-RTD
 Funding Scheme RIA
 Starting year 2019
 Duration (year-month-day) from 2019-01-01   to  2022-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER FR (LYON CEDEX 08) coordinator 720˙000.00
2    THE UNIVERSITY OF TENNESSEE US (KNOXVILLE) participant 647˙121.00
3    UNIVERSITY OF GLASGOW UK (GLASGOW) participant 300˙000.00
4    UNIVERSITA DEGLI STUDI DI TORINO IT (TORINO) participant 257˙203.00
5    INSTITUT CATALA D'ONCOLOGIA ES (L'HOSPITALET DEL LLOBREGAT) participant 249˙985.00
6    Universidad El Bosque CO (Bogota) participant 240˙000.00
7    UNIVERSITY OF BRISTOL UK (BRISTOL) participant 220˙018.00
8    UNIVERZITA KARLOVA CZ (PRAHA 1) participant 140˙000.00
9    DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG DE (HEIDELBERG) participant 139˙118.00
10    UNIVERSIDAD DE BUENOS AIRES AR (BUENOS AIRES) participant 120˙000.00
11    UNIVERSIDAD DE LA REPUBLICA UY (Montevideo) participant 120˙000.00
12    ASSOCIACAO FEMININA DE EDUCACAO E COMBATE AO CANCER BR (VITORIA) participant 0.00
13    FUNDACAO ANTONIO PRUDENTE BR (SAO PAULO) participant 0.00
14    FUNDACAO PIO XII BR (BARRETOS) participant 0.00
15    MINISTERIO DA SAUDE BR (BRASILIA) participant 0.00

Map

 Project objective

Worldwide, more than 550,000 new cases of head and neck cancer (HNC) occur each year, resulting in approximately 300,000 deaths annually. It is the 6th most common cancer in both Europe and South America. A major reason for the high mortality rate for this cancer is the late stage of diagnosis for many patients. Accurate assessment of the prognosis of HNC cases also allows for appropriate treatment decisions. HEADSpAcE will bring together a consortium of 15 partners with a long and successful record of collaboration in HNC. The impact of HEADSpAcE will be to understand reasons for late diagnosis and reduce the proportion of HNC that are diagnosed at a very late stage. It will identify the most appropriate fashion for diagnosis cancer caused by human papilloma virus, and also provide genomic evidence of strong predictors of prognosis that will have the potential to improve care and reduce treatment related morbidity. We will also develop guidelines for implementation into clinical care.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "HEADSPACE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "HEADSPACE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

DIAdIC (2019)

Evaluation of Dyadic Psychoeducational Interventions for People with Advanced Cancer and their Informal Caregivers (DIAdIC): An international randomized controlled trial

Read More  

ENDOSCAPE (2019)

ENDOSCAPE, a clinically applicable non-viral gene delivery technology

Read More  

PD_Pal (2019)

Palliative care in Parkinson’s disease

Read More